EP2245067 - METHODS OF USING CADHERIN 11 (CDH11) ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.11.2013 Database last updated on 19.10.2024 | Most recent event Tooltip | 01.11.2013 | Application deemed to be withdrawn | published on 04.12.2013 [2013/49] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2010/44] | Inventor(s) | 01 /
SAINT-MEZARD, Pierre Novartis Pharma AG Postfach 4002 Basel / CH | [2010/44] | Representative(s) | Kassow, Anders Novartis Pharma AG Patent Department 4002 Basel / CH | [N/P] |
Former [2010/44] | Kassow, Anders Novartis Pharma AG Patent Department 4002 Basel / CH | Application number, filing date | 09711479.7 | 09.02.2009 | [2010/44] | WO2009EP51467 | Priority number, date | US20080065381 | 11.02.2008 Original published format: US 65381 | [2010/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009101059 | Date: | 20.08.2009 | Language: | EN | [2009/34] | Type: | A2 Application without search report | No.: | EP2245067 | Date: | 03.11.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.08.2009 takes the place of the publication of the European patent application. | [2010/44] | Search report(s) | International search report - published on: | EP | 17.06.2010 | Classification | IPC: | C07K16/28, A61P13/12, A61P37/06 | [2010/44] | CPC: |
C07K14/705 (EP,US);
A61P1/16 (EP);
A61P11/00 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P19/02 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/44] | Title | German: | VERFAHREN ZUR VERWENDUNG VON CADHERIN 11 (CDH11)-ANTAGONISTEN | [2010/44] | English: | METHODS OF USING CADHERIN 11 (CDH11) ANTAGONISTS | [2010/44] | French: | PROCÉDÉS D'UTILISATION D'ANTAGONISTES DE LA CADHÉRINE 11 (CDH11) | [2010/44] | Entry into regional phase | 13.09.2010 | National basic fee paid | 17.12.2010 | Designation fee(s) paid | 17.12.2010 | Examination fee paid | Examination procedure | 04.11.2010 | Amendment by applicant (claims and/or description) | 17.12.2010 | Examination requested [2011/04] | 13.02.2013 | Despatch of a communication from the examining division (Time limit: M04) | 25.06.2013 | Application deemed to be withdrawn, date of legal effect [2013/49] | 31.07.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/49] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.02.2013 | Fees paid | Renewal fee | 15.02.2011 | Renewal fee patent year 03 | 15.02.2012 | Renewal fee patent year 04 | 28.02.2013 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY] - FORINO MONICA ET AL, "TGF beta 1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture", INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, (200606), vol. 87, no. 3, ISSN 0959-9673, pages 197 - 208, XP002553818 [X] 1,2 * the whole document * [Y] 3-18 DOI: http://dx.doi.org/10.1111/j.1365-2613.2006.00479.x | [Y] - WYNN T A, "Cellular and molecular mechanisms of fibrosis", JOURNAL OF PATHOLOGY, (200801), vol. 214, no. 2, ISSN 0022-3417, pages 199 - 210, XP002553819 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1002/path.2277 | [Y] - BEDI ET AL, "Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis", TRANSPLANTATION REVIEWS, GRUNE & STRATTON, ORLANDO, FL, US, (20071123), vol. 22, no. 1, ISSN 0955-470X, pages 1 - 5, XP022353103 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1016/j.trre.2007.09.004 | [Y] - WARD ET AL, "Hypothesis: Epithelial-to-Mesenchymal Transition is a Common Cause of Chronic Allograft Failure", TRANSPLANTATION PROCEEDINGS, ORLANDO, FL, US, (20050418), vol. 37, no. 2, ISSN 0041-1345, pages 977 - 980, XP022309686 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1016/j.transproceed.2004.12.203 | [Y] - HERTIG A ET AL, "Risk factors for early epithelial to mesenchymal transition in renal grafts", AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL MUNKSGAARD, DK, vol. 6, no. 12, ISSN 1600-6135, (20061201), pages 2937 - 2946, (20061025), XP009125335 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1111/j.1600-6143.2006.01559.x | [Y] - BINKLEY CHARLES E ET AL, "The molecular basis of pancreatic fibrosis - Common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma", PANCREAS, RAVEN PRESS, NEW YORK, NY, US, (20041101), vol. 29, no. 4, ISSN 0885-3177, pages 254 - 263, XP009125254 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1097/00006676-200411000-00003 | [Y] - ZEISBERG ELISABETH M ET AL, "Endothelial-to-mesenchymal transition contributes to cardiac fibrosis", NATURE MEDICINE, (200708), vol. 13, no. 8, ISSN 1078-8956, pages 952 - 961, XP002553821 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1038/nm1613 | [Y] - LIU Y, "Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, WILLIAMS AND WILKINS, BALTIMORE, MD, US, (20040101), vol. 15, no. 1, ISSN 1046-6673, pages 1 - 12, XP003015975 [Y] 2-18 * the whole document * DOI: http://dx.doi.org/10.1097/01.ASN.0000106015.29070.E7 | [DA] - VASKO VASILY ET AL, "Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (200702), vol. 104, no. 8, ISSN 0027-8424, pages 2803 - 2808, XP002555393 [DA] * the whole document * DOI: http://dx.doi.org/10.1073/pnas.0610733104 | [A] - LEE DAVID M ET AL, "Cadherin-11 in synovial lining formation and pathology in arthritis", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 315, no. 5814, ISSN 1095-9203, (20070216), pages 1006 - 1010, (20070125), XP002528086 [A] * the whole document * DOI: http://dx.doi.org/10.1126/SCIENCE.1137306 | [A] - TOMITA KYOICHI ET AL, "Cadherin switching in human prostate cancer progression", CANCER RESEARCH, (20000701), vol. 60, no. 13, ISSN 0008-5472, pages 3650 - 3654, XP002555394 [A] * the whole document * | [A] - PISHVAIAN M J ET AL, "CADHERIN-11 IS EXPRESSED IN INVASIVE BREAST CANCER CELL LINES", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD., US, (19990815), vol. 59, no. 4, ISSN 0008-5472, pages 947 - 952, XP000877301 [A] * the whole document * |